SIRT2 and Glucose intolerance: While NMN treatment ameliorated glucose intolerance in obese HFD-fed mice, Sirt2 knockdown partially negated the blood glucose-lowering effects of NMN in a glucose tolerance test when endogenous insulin secretion was inhibited by somatostatin administration (Fig. 2e and Supplementary Fig. 3c).